Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
13 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.80
Open
$1.80
Day's High
$1.80
Day's Low
$1.80
Volume
15
Avg. Vol
2,619
52-wk High
$4.21
52-wk Low
$1.56

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.28 -0.098
Jun '18 0.39 -0.075
Mar '18 0.23 -0.109
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. 9.46 148.17 46.24
P/E Low - Last 5 Yrs. 9.46 47.84 24.59
Beta -0.19 1.08 0.91
Price to Sales (TTM) 13.52 49.58 6.22
Price to Book (MRQ) 8.54 10.17 5.20
Price to Tangible Book (MRQ) 8.54 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 4.64 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.15 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -7.80 47.89 6.50
Sales - 5 Yr. Growth Rate -16.73 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.65 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -59.84 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 5.16 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -195.94 -- --
EBITD - 5 Yr. Avg -377.16 -109.98 13.16
Operating Margin (TTM) -197.09 -185.00 6.07
Operating Margin - 5 Yr. Avg. -320.58 -126.42 8.47
Pre-Tax Margin (TTM) -253.47 -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -264.44 -132.58 8.71
Net Profit Margin (TTM) -253.47 -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -264.44 -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,134 7,649,006 873,053,182
Net Income/Employee (TTM) -492,081 653,334 103,483,965
Receivable Turnover (TTM) 4.40 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.19 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.89 6.47 11.45
Return on Assets - 5 Yr. Avg. -57.32 5.54 12.50
Return on Investment (TTM) -119.26 9.01 14.96
Return on Investment - 5 Yr. Avg. -262.99 6.87 16.23
Return on Equity (TTM) -119.07 10.15 16.52
Return on Equity - 5 Yr. Avg. -367.36 8.41 17.37
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.00%
# of Holders: 24
Total Shares Held: 678,354
3 Mo. Net Change: 365
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 1
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.